Our findings demonstrate that the targeting of C1QBP by PDBAG1 leads to mitochondrial destruction, induction of homologous‐recombination deficiency, and sensitisation of TNBC cancer cells with non‐BRCA mutations to PARPis. This evidence concerns the gene C1QBP and cancer.